Home LiteratureArticle Details
PMID: 21656330 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

Diabetologia ·Vol. 54 ·No. 10 ·2011-10-00 ·Pages 2506-14

Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R

Abstract

Type 2 diabetes is regarded as inevitably progressive, with irreversible beta cell failure. The hypothesis was tested that both beta cell failure and insulin resistance can be reversed by dietary restriction of energy intake. Eleven people with type 2 diabetes (49.5 ± 2.5 years, BMI 33.6 ± 1.2 kg/m(2), nine male and two female) were studied before and after 1, 4 and 8 weeks of a 2.5 MJ (600 kcal)/day diet. Basal hepatic glucose output, hepatic and peripheral insulin sensitivity and beta cell function were measured. Pancreas and liver triacylglycerol content was measured using three-point Dixon magnetic resonance imaging. An age-, sex- and weight-matched group of eight non-diabetic participants was studied. After 1 week of restricted energy intake, fasting plasma glucose normalised in the diabetic group (from 9.2 ± 0.4 to 5.9 ± 0.4 mmol/l; p = 0.003). Insulin suppression of hepatic glucose output improved from 43 ± 4% to 74 ± 5% (p = 0.003 vs baseline; controls 68 ± 5%). Hepatic triacylglycerol content fell from 12.8 ± 2.4% in the diabetic group to 2.9 ± 0.2% by week 8 (p = 0.003). The first-phase insulin response increased during the study period (0.19 ± 0.02 to 0.46 ± 0.07 nmol min(-1) m(-2); p < 0.001) and approached control values (0.62 ± 0.15 nmol min(-1) m(-2); p = 0.42). Maximal insulin response became supranormal at 8 weeks (1.37 ± 0.27 vs controls 1.15 ± 0.18 nmol min(-1) m(-2)). Pancreatic triacylglycerol decreased from 8.0 ± 1.6% to 6.2 ± 1.1% (p = 0.03). Normalisation of both beta cell function and hepatic insulin sensitivity in type 2 diabetes was achieved by dietary energy restriction alone. This was associated with decreased pancreatic and liver triacylglycerol stores. The abnormalities underlying type 2 diabetes are reversible by reducing dietary energy intake.

MeSH Terms
Adult Aged Blood Glucose/metabolism Body Composition/physiology Body Weight/physiology Diabetes Mellitus, Type 2/diet therapy,metabolism,physiopathology Female Glycated Hemoglobin A/metabolism Humans Insulin-Secreting Cells/physiology Liver/metabolism Male Middle Aged Pancreas/metabolism Triglycerides/metabolism
Chemicals
Blood Glucose Glycated Hemoglobin A Triglycerides
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lim E L
Magnetic Resonance Centre, Institute of Cellular Medicine, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Hollingsworth K G
Aribisala B S
Chen M J
Mathers J C
Taylor R
References (46)
46 references, click to expand
  1. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents.
    Int J Obes (Lond). 2010 Feb;34(2):396-400 PMID: 20010902
  2. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.
    Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10878-82 PMID: 7971976
  3. Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction.
    Magn Reson Med. 1991 Apr;18(2):371-83 PMID: 2046518
  4. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2008 Jul;93(7):2479-85 PMID: 18430778
  5. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.
    Diabetes Care. 2010 Aug;33(8):1817-22 PMID: 20668154
  6. Insulin secretion in diabetes mellitus.
    Am J Med. 1981 Mar;70(3):579-88 PMID: 7011013
  7. Glucose clamp technique: a method for quantifying insulin secretion and resistance.
    Am J Physiol. 1979 Sep;237(3):E214-23 PMID: 382871
  8. {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes.
    Endocrinology. 2010 Apr;151(4):1462-72 PMID: 20176718
  9. Effect of acute hyperglycemia on insulin secretion in humans.
    Diabetes. 2002 Feb;51 Suppl 1:S130-3 PMID: 11815471
  10. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes. 1995 Nov;44(11):1249-58 PMID: 7589820
  11. Diacylglycerol-mediated insulin resistance.
    Nat Med. 2010 Apr;16(4):400-2 PMID: 20376053
  12. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion.
    Diabetes. 2005 Feb;54(2):472-81 PMID: 15677505
  13. ISEC: a program to calculate insulin secretion.
    Comput Methods Programs Biomed. 1996 Aug;50(3):253-64 PMID: 8894385
  14. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.
    Gastroenterology. 2009 May;136(5):1552-60 PMID: 19208352
  15. Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes.
    Diabetes. 2003 Jun;52(6):1485-95 PMID: 12765961
  16. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.
    Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8 PMID: 15339742
  17. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
    Diabetes. 2008 Sep;57(9):2288-95 PMID: 18535187
  18. Dose-response characteristics for effects of insulin on production and utilization of glucose in man.
    Am J Physiol. 1981 Jun;240(6):E630-9 PMID: 7018254
  19. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet. 1998 Sep 12;352(9131):837-53 PMID: 9742976
  20. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
    Ann Surg. 2004 Aug;240(2):236-42 PMID: 15273546
  21. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause.
    Diabetologia. 2008 Oct;51(10):1781-9 PMID: 18726585
  22. Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?
    Diabetologia. 2009 Nov;52(11):2270-2276 PMID: 19727661
  23. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes.
    Clin Anat. 2007 Nov;20(8):933-42 PMID: 17879305
  24. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Int J Obes (Lond). 2010 Mar;34(3):462-71 PMID: 20029383
  25. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.
    Diabetes. 2003 Oct;52(10):2461-74 PMID: 14514628
  26. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.
    Biochem Soc Trans. 2008 Jun;36(Pt 3):348-52 PMID: 18481955
  27. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.
    Diabetes Care. 2007 Nov;30(11):2916-21 PMID: 17666465
  28. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
    Ann Surg. 2006 Nov;244(5):741-9 PMID: 17060767
  29. The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic beta-cells.
    Biochem Soc Trans. 2008 Oct;36(Pt 5):905-8 PMID: 18793159
  30. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
    Obesity (Silver Spring). 2008 Feb;16(2):298-305 PMID: 18239636
  31. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.
    Diabetologia. 2010 Jul;53(7):1395-405 PMID: 20369226
  32. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.
    J Biol Chem. 2010 Feb 26;285(9):6706-15 PMID: 20034933
  33. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastroenterology. 2007 Aug;133(2):496-506 PMID: 17681171
  34. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass.
    Ann Surg. 1987 Sep;206(3):316-23 PMID: 3632094
  35. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
    Diabetes. 2005 Mar;54(3):603-8 PMID: 15734833
  36. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    J Clin Invest. 1999 Sep;104(6):787-94 PMID: 10491414
  37. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content.
    Diabetes. 2003 Mar;52(3):701-7 PMID: 12606511
  38. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Am J Physiol Endocrinol Metab. 2006 Oct;291(4):E697-703 PMID: 16684857
  39. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
    Diabetologia. 2003 Jan;46(1):3-19 PMID: 12637977
  40. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique.
    Metabolism. 1996 Jan;45(1):82-91 PMID: 8544782
  41. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.
    Diabetes. 2006 Jul;55(7):2025-31 PMID: 16804072
  42. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes: response to Tushuizen et al.
    Diabetes Care. 2008 May;31(5):e38; author reply e39 PMID: 18445718
  43. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
    Obes Surg. 2006 Dec;16(12):1594-601 PMID: 17217635
  44. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
    Diabetes. 1992 Mar;41(3):368-77 PMID: 1551497
  45. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.
    Diabetes Care. 2010 Jul;33(7):1438-42 PMID: 20368410
  46. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
    Diabetes. 2003 Jan;52(1):102-10 PMID: 12502499
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
1432-0428
Published
2011-10-00
Epub
2011-00-09
Pages
2506-14
Language
English
Region
Germany
NLM ID
0006777
PMCID
PMC3168743
Subset
IM
Grants
Medical Research Council · G0900686 · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]